Published in Dig Dis Sci on October 01, 1998
Bone growth during rapamycin therapy in young rats. BMC Pediatr (2009) 0.94
Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Br J Pharmacol (2004) 0.93
Rapamycin Inhibition of mTOR Reduces Levels of the Na+/H+ Exchanger 3 in Intestines of Mice and Humans, Leading to Diarrhea. Gastroenterology (2015) 0.80
Intestinal Epithelial-Specific mTORC1 Activation Enhances Intestinal Adaptation After Small Bowel Resection. Cell Mol Gastroenterol Hepatol (2016) 0.75
Cyclosporine. N Engl J Med (1989) 5.67
Intestinal permeability: an overview. Gastroenterology (1995) 5.36
Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest (1989) 4.28
Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology (1994) 3.60
Chemokines, inflammation and the immune system. Ther Immunol (1994) 1.86
Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res (1995) 1.73
Integrative immunophysiology in the intestinal mucosa. Am J Physiol (1994) 1.40
Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol (1993) 1.30
Rapamune (Sirolimus, rapamycin): an overview and mechanism of action. Ther Drug Monit (1995) 1.18
The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J Clin Invest (1976) 1.15
Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. J Clin Invest (1994) 1.07
Inhibition of liver, kidney, and intestine regeneration by rapamycin. Transplantation (1992) 1.00
Effect of diet on glucose transporter site density along the intestinal crypt-villus axis. Am J Physiol (1992) 0.97
Validation of a chamber that allows measurement of both tissue uptake rates and unstirred layer thicknesses in the intestine under conditions of controlled stirring. Gastroenterology (1974) 0.97
Intestinal epithelial function: the case for immunophysiological regulation. Cells and mediators (1). Dig Dis Sci (1993) 0.96
Neuroimmunomodulation in the intestinal mucosa. Gastroenterol Clin North Am (1991) 0.95
Intestinal adaptation to diabetes. Altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats. J Clin Invest (1987) 0.94
FK506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology (1995) 0.94
Glucose transport and microvillus membrane physical properties along the crypt-villus axis of the rabbit. J Clin Invest (1990) 0.88
New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev (1993) 0.84
Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation. Transplantation (1994) 0.84
Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. Transplantation (1991) 0.84
Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Rapamycin efficacy is blood level related. Transplantation (1993) 0.84
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. Transplantation (1995) 0.82
Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation (1995) 0.82
Cyclosporine augments hepatic regenerative response in rats. Dig Dis Sci (1990) 0.81
The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. Transplantation (1993) 0.79
Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat. Transplant Proc (1992) 0.79
Immunosuppressants: tools to investigate the physiological role of cytokines. Bioessays (1993) 0.79
Crypt cell production rate, enterocyte turnover time and appearance of transport along the jejunal villus of the rat. Biochim Biophys Acta (1994) 0.79
Insulin regulates Na+/glucose cotransporter activity in rat small intestine. Biochim Biophys Acta (1991) 0.79
Cyclosporin binding to a protein component of the renal Na(+)-D-glucose cotransporter. J Biol Chem (1990) 0.79
FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system. Dig Dis Sci (1995) 0.78
Intestinal morphology, marker enzymes and lipid content of brush border membranes from rabbit jejunum and ileum: effect of aging. Mech Ageing Dev (1985) 0.77
In vivo and in vitro effects of cyclosporin A on glucose transport by soleus muscles of mice. Biochem Pharmacol (1992) 0.77
Nutritional and intestinal effects of the novel immunosuppressive agents: deoxyspergualin, rapamycin, and mycophenolate mofetil. Clin Biochem (1996) 0.76
Chronic cyclosporine-induced nephrotoxicity: a rabbit model. Transplantation (1994) 0.75
Orally administered immunosuppressants modify intestinal uptake of nutrients in rabbits. Transplantation (1994) 0.75
Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography. Ther Drug Monit (1992) 0.75
Use of a monoclonal antibody for the therapeutic monitoring of cyclosporine in plasma and whole blood. Ther Drug Monit (1988) 0.75
Influence of site and unstirred layers on the rate of uptake of cholesterol and fatty acids into rabbit intestine. J Lipid Res (1980) 0.75
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut (2000) 2.67
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med (1994) 2.52
The radiosensitivity of the human oocyte. Hum Reprod (2003) 1.81
Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Gut (1988) 1.54
A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group. Can J Gastroenterol (1997) 1.51
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleeding. Am J Gastroenterol (2000) 1.49
Nutritional effects of surgical and medical treatment for short bowel syndrome. JPEN J Parenter Enteral Nutr (2001) 1.44
Endothelium-dependent relaxation in aorta of BB rat. Diabetes (1987) 1.44
Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group. Can J Gastroenterol (1999) 1.43
Interference of fetal hemoglobin and labile glycosylated hemoglobin with measurements of glycosylated hemoglobin. Clin Chem (1983) 1.39
Therapeutic monitoring of cyclosporine, FK-506, and rapamycin. Ther Drug Monit (1992) 1.39
Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance. Clin Chem (1990) 1.39
Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology (2000) 1.39
Derivation of the equations that describe the effects of unstirred water layers on the kinetic parameters of active transport processes in the intestine. J Theor Biol (1977) 1.32
Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. Can J Physiol Pharmacol (1985) 1.31
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology (1996) 1.31
Conservation of genes coding for proteins synthesized in human mitochondria. Somatic Cell Genet (1978) 1.19
Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. Can J Gastroenterol (1998) 1.19
Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease. Gastroenterology (1982) 1.18
Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panel. Clin Chem (1990) 1.16
Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Can J Physiol Pharmacol (1993) 1.14
Delta 6-desaturase activity in liver microsomes of rats fed diets enriched with cholesterol and/or omega 3 fatty acids. Biochem J (1988) 1.11
Iron deficiency in inflammatory bowel disease. Diagnostic efficacy of serum ferritin. Am J Dig Dis (1978) 1.10
Impairment of endothelium-dependent relaxation: an early marker for atherosclerosis in the rabbit. Br J Pharmacol (1988) 1.10
Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr (1998) 1.08
Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol (1998) 1.07
Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol (2000) 1.06
Dietary fat selectively alters transport properties of rat jejunum. J Clin Invest (1986) 1.06
Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. Can J Gastroenterol (1998) 1.05
Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem (1990) 1.04
Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients. Gastroenterology (1992) 1.03
Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol (1988) 1.01
Acidosis and lipopolysaccharide from Escherichia coli B:055 cause hyperpermeability of rumen and colon tissues. J Dairy Sci (2007) 1.01
Does iron deficiency raise the seizure threshold? J Child Neurol (1995) 1.00
Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta. Can J Physiol Pharmacol (1986) 0.99
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother (2003) 0.99
Serum ferritin levels in anemia of rheumatoid arthritis. J Rheumatol (1977) 0.99
Tacrolimus metabolite cross-reactivity in different tacrolimus assays. Clin Biochem (1998) 0.98
Aspergillus terreus infective endocarditis on a porcine heterograft valve. J Thorac Cardiovasc Surg (1980) 0.98
Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res (1999) 0.98
Altered glucose carrier expression: mechanism of intestinal adaptation during streptozocin-induced diabetes in rats. Am J Physiol (1991) 0.97
Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography. Clin Chem (1984) 0.96
The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol (1998) 0.96
Alteration of the lipid composition of rat testicular plasma membranes by dietary (n-3) fatty acids changes the responsiveness of Leydig cells and testosterone synthesis. J Nutr (1990) 0.95
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease. Can J Gastroenterol (1997) 0.94
Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats. JPEN J Parenter Enteral Nutr (1997) 0.94
The physiology of adaptation to small bowel resection in the pig: an integrated study of morphological and functional changes. J Pediatr Surg (1990) 0.93
Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group. Can J Gastroenterol (2000) 0.93
The role of apolipoprotein A-IV in the regulation of food intake. Annu Rev Nutr (2001) 0.93
VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation. Can J Gastroenterol (2008) 0.93
Cyclosporine metabolite cross-reactivity in different cyclosporine assays. Clin Biochem (1998) 0.93
Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update. Clin Biochem (1998) 0.93
Adaptation following intestinal resection: mechanisms and signals. Best Pract Res Clin Gastroenterol (2003) 0.92
Intestinal aspects of lipid absorption: in review. Can J Physiol Pharmacol (1989) 0.92
Coronary artery wounds treated with saphenous vein bypass grafts. JAMA (1973) 0.91
Gastrin, gastric emptying, and gastroesophageal reflux after ranitidine. J Clin Gastroenterol (1983) 0.91
Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr (1998) 0.91
In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD. Clin Exp Immunol (1979) 0.91
Vitamin A status in 137 patients with Crohn's disease. Digestion (1987) 0.91
Recurrent Clostridium difficile-associated colitis responding to cholestyramine. Digestion (1986) 0.91
Lewis antigen expression by Helicobacter pylori. J Infect Dis (2001) 0.90
Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? Fertil Steril (2000) 0.89
Effect of dietary cholesterol and/or omega 3 fatty acids on lipid composition and delta 5-desaturase activity of rat liver microsomes. J Nutr (1988) 0.89
Experimental demonstration of the effect of the unstirred water layer on the kinetic constants of the membrane transport of D-glucose in rabbit jejunum. J Membr Biol (1980) 0.88
Preservation of fertility in children treated for cancer. Arch Dis Child (2003) 0.88
Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer. Clin Ther (1984) 0.88
Dietary cholesterol and/or n-3 fatty acid modulate delta 9-desaturase activity in rat liver microsomes. Biochim Biophys Acta (1988) 0.88
Interactions of saturated, n-6 and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism. J Lipid Res (1990) 0.87
Na(+)-K(+)-ATPase alpha 1- and beta 1-mRNA and protein levels in rat small intestine in experimental ileitis. Am J Physiol (1995) 0.87
Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease. Clin Ther (1984) 0.87
Quantitative sacroiliac scintigraphy in patients with Crohn's disease. Arthritis Rheum (1978) 0.87
Barley-derived β-glucans increases gut permeability, ex vivo epithelial cell binding to E. coli, and naive T-cell proportions in weanling pigs. J Anim Sci (2012) 0.87
Pharmacokinetics and metabolism of sirolimus. Ther Drug Monit (2000) 0.87
Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation (1996) 0.87
Effect of chlorhexidine mouthrinse and periodontal treatment upon bacteremia produced by oral hygiene procedures. Scand J Dent Res (1974) 0.87
Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J (1988) 0.86
Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study. Dig Dis Sci (1985) 0.86
Review article: older systemic and newer topical glucocorticosteroids and the gastrointestinal tract. Aliment Pharmacol Ther (1996) 0.86
Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents. Can J Gastroenterol (1999) 0.86
A physiological level of rhubarb fiber increases proglucagon gene expression and modulates intestinal glucose uptake in rats. J Nutr (1997) 0.86
Inhibition of lipid absorption as an approach to the treatment of obesity. Methods Enzymol (1997) 0.86
Ontogeny of intestinal adaptation in rats in response to isocaloric changes in dietary lipids. Am J Physiol (1997) 0.85
Evaluation of the CLINITEK ATLAS for routine macroscopic urinalysis. Clin Biochem (1996) 0.85
Current opinions on therapeutic drug monitoring of immunosuppressive drugs. Clin Ther (1999) 0.85
Use of polyunsaturated fatty acid diet to treat the enhanced intestinal uptake of lipids in streptozotocin diabetic rats. Clin Invest Med (1988) 0.85
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Inflamm Bowel Dis (2000) 0.85
Marital idiopathic inflammatory bowel disease. Crohn's disease in a husband and wife. J Clin Gastroenterol (1988) 0.84
Convergence of three methods to resolve discrepant immunoassay digitoxin results. Clin Chem (1997) 0.84
Pancreatic injury following ERCP. Failure of prophylactic benefit of Trasylol. Gastrointest Endosc (1977) 0.84
Nutritional status of gastroenterology outpatients: comparison of inflammatory bowel disease with functional disorders. J Am Diet Assoc (1985) 0.84
Intestinal kinetic parameters: effects of unstirred layers and transport preparation. Am J Physiol (1980) 0.84
Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology (1997) 0.84
Interrelation of intestinal transport system for manganese and iron. J Lab Clin Med (1971) 0.84
Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Rapamycin efficacy is blood level related. Transplantation (1993) 0.84
Ranitidine versus cimetidine in the management of acute upper gastrointestinal tract bleeding. J Clin Gastroenterol (1984) 0.83